BACE1 and Alzheimer disease: Detailed characterization of Aβ species occurring in AD patient brains revealed not only elevated Aβ1-x, but also different N-terminally truncated Aβ species such as Aβ2-42, which cannot be assigned to BACE1 activity [20].